SKITUDE
4.6.2019 16:46:10 CEST | Business Wire | Press release
The merger of Skitude, the largest network of skiing apps, and the Skioo innovative skipass technology, which provides access to ski resorts with a single card and no waiting in line, aims to optimise sales channels for the more than 150 partnering ski resorts for the upcoming season.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190604005775/en/
Alongside may other advantages, the strategy will consist of using post-payment systems to facilitate the user’s skiing experience, streamlining their access to the slopes, and helping the ski resorts position their products on their online platform.
“We are working so that skiers can purchase a ski pass ahead of time and load the ticket on their RFID card, or validate beforehand using a credit card, easily from their mobile on”, explained Skitude CEO Marc Bigas. “These principles of convenience and post-payment are already well-known thanks to popular services like Uber”, he added.
As a result, Skitude Chairman Yngve Tvedt explains, the combined digital platform will add a new dimension to the ski industry with a digital journey that is simpler and fun.
Thus, Tvedt assures, Skitude is participating in the “digitalisation of the sector” and agrees with Marc Bigas that this experience will offer “more convenience to the skier” as well as “powerful solutions for the mobile sales channels and marketing services” that will help ski resorts stay better connected with the needs of their current and potential customers.
New challenges
The merger of the two companies is also aimed at finding a way to push back against the stagnation of users in the industry, one of the sector's main challenges. “We are setting off on a journey to meet challenges using technology”, the company’s CEO stated, adding that the experience built up by both Skitude and Skioo over the years will become “valuable information for ski resorts”.
It is worth noting that the Girona-based company has always been committed to interacting with users “before, during and after their visit”, which, according to Bigas, “strengthens the competitiveness of the industry and enables it to continue moving forward”.
A community of more than 1.3 million skiers
The Skitude community is currently made up of more than 1.3 million skiers who have used the free applications that are compatible with the Skitude platform, most of them being the official applications of ski resorts.
It is a very active community. Thanks to the GPS Tracker that can log their runs, users have already logged activity at more than 1,200 ski resorts in 45 countries worldwide, and have been able to participate in more than 250 Challenges allowing them to win ski days, equipment like skis, boots or action cameras, and exclusive discounts.
The operation will allow consolidating the international project of 50 people, with offices in Girona, Lausanne and Oslo, and to continue researching to find dynamic solutions and improve the customer experience at ski resorts.
The shareholders of the company are comprised of the entrepreneurial partners Marc Bigas and David Huerva, Spanish investment funds, as well as the three Norwegian funds that own Skioo: Investinor, Canica and Norselab. Norselab counts the Olympic alpine ski champion Aksel Lund Svindal as an investor.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190604005775/en/
Contact:
For more information: Àric Monterde +34-972-001-021 aric.monterde@skitude.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer samarbejdsfirmaet TechSparq25.10.2026 06:09:00 CET | Pressemeddelelse
Andersen Consulting udvider sine kompetencer inden for teknologi og forretningstransformation gennem en samarbejdsaftale med TechSparq, en amerikansk virksomhed, der kombinerer strategi, commerce engineering og ai med praktisk implementering. TechSparq er et digitalt konsulenthus, der tilbyder strategi- og rådgivningstjenester, commerce engineering samt tjenester inden for ai og agentbaseret handel til virksomheder inden for detailhandel og forbrugsgoder, luksus og mode samt e-handel og direkte salg til forbrugere. Virksomheden har hovedkontor i Oregon og kombinerer strategisk planlægning med praktisk implementering for at hjælpe kunderne med at udvikle deres digitale initiativer, kundeoplevelse og driftsmodeller. "Vi etablerede vores virksomhed for at bygge bro mellem dem, der udvikler strategien, og dem, der har ansvaret for at føre den ud i livet," udtalte Dedrick Boyd, stifter af og administrerende direktør for TechSparq. "Vores samarbejde med Andersen Consulting giver os mulighed
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom